Your browser doesn't support javascript.
loading
Tumor Lysis, Adverse Events, and Dose Adjustments in 297 Venetoclax-Treated CLL Patients in Routine Clinical Practice.
Roeker, Lindsey E; Fox, Christopher P; Eyre, Toby A; Brander, Danielle M; Allan, John N; Schuster, Stephen J; Nabhan, Chadi; Hill, Brian T; Shah, Nirav N; Lansigan, Frederick; Yazdy, Maryam; Cheson, Bruce D; Lamanna, Nicole; Singavi, Arun K; Coombs, Catherine C; Barr, Paul M; Skarbnik, Alan P; Shadman, Mazyar; Ujjani, Chaitra S; Tuncer, Hande H; Winter, Allison M; Rhodes, Joanna; Dorsey, Colleen; Morse, Hannah; Kabel, Charlene; Pagel, John M; Williams, Annalynn M; Jacobs, Ryan; Goy, Andre; Muralikrishnan, Sivraj; Pearson, Laurie; Sitlinger, Andrea; Bailey, Neil; Schuh, Anna; Kirkwood, Amy A; Mato, Anthony R.
Afiliación
  • Roeker LE; Leukemia Service, Memorial Sloan-Kettering Cancer Center, New York, New York.
  • Fox CP; Department of Clinical Haematology, Nottingham University Hospitals NHS Foundation Trust, Nottingham, United Kingdom.
  • Eyre TA; Oxford University Hospitals NHS Foundation Trust, Oxford, United Kingdom.
  • Brander DM; Duke Cancer Institute, Duke University Health System, Durham, North Carolina.
  • Allan JN; Division of Hematology and Oncology, Weill Cornell Medicine, New York, New York.
  • Schuster SJ; Lymphoma Program, Abramson Cancer Center, University of Pennsylvania, Philadelphia, Pennsylvania.
  • Nabhan C; Aptitude Health, Atlanta, GA.
  • Hill BT; Taussig Cancer Institute, Cleveland Clinic, Cleveland, Ohio.
  • Shah NN; Division of Hematology & Oncology, Medical College of Wisconsin, Milwaukee, Wisconsin.
  • Lansigan F; Dartmouth-Hitchcock Medical Center, Lebanon, New Hampshire.
  • Yazdy M; Georgetown University Hospital Lombardi Comprehensive Cancer Center, Washington, D.
  • Cheson BD; Georgetown University Hospital Lombardi Comprehensive Cancer Center, Washington, D.
  • Lamanna N; Hematology/Oncology Division, Columbia University Medical Center, New York, New York.
  • Singavi AK; Division of Hematology & Oncology, Medical College of Wisconsin, Milwaukee, Wisconsin.
  • Coombs CC; Lineberger Comprehensive Cancer Center, University of North Carolina, Chapel Hill, North Carolina.
  • Barr PM; Wilmot Cancer Institute, University of Rochester, Rochester, New York.
  • Skarbnik AP; John Theurer Cancer Center, Hackensack University Medical Center, Closter, New Jersey.
  • Shadman M; Fred Hutchinson Cancer Research Center, Seattle, Washington.
  • Ujjani CS; Fred Hutchinson Cancer Research Center, Seattle, Washington.
  • Tuncer HH; Tufts Medical Center, Boston, Massachusetts.
  • Winter AM; Taussig Cancer Institute, Cleveland Clinic, Cleveland, Ohio.
  • Rhodes J; Lymphoma Program, Abramson Cancer Center, University of Pennsylvania, Philadelphia, Pennsylvania.
  • Dorsey C; Leukemia Service, Memorial Sloan-Kettering Cancer Center, New York, New York.
  • Morse H; Leukemia Service, Memorial Sloan-Kettering Cancer Center, New York, New York.
  • Kabel C; Leukemia Service, Memorial Sloan-Kettering Cancer Center, New York, New York.
  • Pagel JM; Swedish Cancer Institute, Seattle, Washington.
  • Williams AM; Wilmot Cancer Institute, University of Rochester, Rochester, New York.
  • Jacobs R; Levine Cancer Institute, Carolinas Healthcare System, Charlotte, North Carolina.
  • Goy A; John Theurer Cancer Center, Hackensack University Medical Center, Closter, New Jersey.
  • Muralikrishnan S; Dartmouth-Hitchcock Medical Center, Lebanon, New Hampshire.
  • Pearson L; Tufts Medical Center, Boston, Massachusetts.
  • Sitlinger A; Duke Cancer Institute, Duke University Health System, Durham, North Carolina.
  • Bailey N; Swedish Cancer Institute, Seattle, Washington.
  • Schuh A; Oxford University Hospitals NHS Foundation Trust, Oxford, United Kingdom.
  • Kirkwood AA; Cancer Research UK and University College London Cancer Trials Centre, London, United Kingdom.
  • Mato AR; Leukemia Service, Memorial Sloan-Kettering Cancer Center, New York, New York. matoa@mskcc.org.
Clin Cancer Res ; 25(14): 4264-4270, 2019 07 15.
Article en En | MEDLINE | ID: mdl-31004001
Asunto(s)
Texto completo
Añadir a Mi BVS
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Contexto en salud: 3_ND Problema de salud: 3_diarrhea Asunto principal: Sulfonamidas / Pautas de la Práctica en Medicina / Leucemia Linfocítica Crónica de Células B / Síndrome de Lisis Tumoral / Compuestos Bicíclicos Heterocíclicos con Puentes / Efectos Colaterales y Reacciones Adversas Relacionados con Medicamentos Tipo de estudio: Observational_studies / Prognostic_studies / Risk_factors_studies Límite: Adult / Aged / Aged80 / Female / Humans / Male / Middle aged Idioma: En Revista: Clin Cancer Res Asunto de la revista: NEOPLASIAS Año: 2019 Tipo del documento: Article
Texto completo
Añadir a Mi BVS
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Contexto en salud: 3_ND Problema de salud: 3_diarrhea Asunto principal: Sulfonamidas / Pautas de la Práctica en Medicina / Leucemia Linfocítica Crónica de Células B / Síndrome de Lisis Tumoral / Compuestos Bicíclicos Heterocíclicos con Puentes / Efectos Colaterales y Reacciones Adversas Relacionados con Medicamentos Tipo de estudio: Observational_studies / Prognostic_studies / Risk_factors_studies Límite: Adult / Aged / Aged80 / Female / Humans / Male / Middle aged Idioma: En Revista: Clin Cancer Res Asunto de la revista: NEOPLASIAS Año: 2019 Tipo del documento: Article